Grantham, Mayo, Van Otterloo & Co (GMO)
SNY icon

Grantham, Mayo, Van Otterloo & Co (GMO)’s Sanofi SNY Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.2M Buy
285,165
+96,094
+51% +$4.29M 0.03% 239
2026
Q1 		$9.11M Buy
189,071
+90,900
+93% +$4.24M 0.02% 250
2025
Q4 		$4.76M Buy
98,171
+13,007
+15% +$645K 0.01% 316
2025
Q3 		$4.02M Buy
85,164
+42,491
+100% +$2.05M 0.01% 310
2025
Q2 		$2.06M Buy
42,673
+6,865
+19% +$351K 0.01% 372
2025
Q1 		$1.99M Buy
35,808
+17,019
+91% +$921K 0.01% 380
2024
Q4 		$906K Buy
+18,789
New +$955K ﹤0.01% 462
2021
Q1 		– Sell
-14,100
Closed -$685K – 928
2020
Q4 		$685K Sell
14,100
-111,642
-89% -$5.51M ﹤0.01% 636
2020
Q3 		$6.31M Sell
125,742
-175,600
-58% -$9.04M 0.04% 206
2020
Q2 		$15.4M Sell
301,342
-125,000
-29% -$6.07M 0.11% 106
2020
Q1 		$18.6M Sell
426,342
-99,200
-19% -$4.75M 0.16% 90
2019
Q4 		$26.4M Sell
525,542
-53,400
-9% -$2.5M 0.18% 95
2019
Q3 		$26.8M Sell
578,942
-33,700
-6% -$1.45M 0.19% 86
2019
Q2 		$26.5M Buy
612,642
+92,200
+18% +$3.92M 0.19% 90
2019
Q1 		$23M Sell
520,442
-7,200
-1% -$308K 0.17% 94
2018
Q4 		$22.9M Sell
527,642
-4,000
-0.8% -$176K 0.18% 87
2018
Q3 		$23.7M Buy
531,642
+77,714
+17% +$3.32M 0.16% 92
2018
Q2 		$18.2M Sell
453,928
-13,772
-3% -$542K 0.13% 107
2018
Q1 		$18.7M Buy
+467,700
New +$19.5M 0.11% 105

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s SNY Position: Q2 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) increased its Sanofi (SNY) stake by 51% in Q2 2026, buying an estimated $4.29M and bringing the position to 285,165 shares worth $12.2M. The position accounts for 0.03% of the portfolio, ranked #239.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in SNY in Q1 2018 and has held it in 19 quarters since. The position peaked at $26.8M in Q3 2019. 716 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) held 285,165 shares of Sanofi worth $12.2M as of Q2 2026.
  • Grantham, Mayo, Van Otterloo & Co (GMO) bought 96,094 Sanofi shares in Q2 2026, an estimated $4.29M.
  • Sanofi made up 0.03% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q2 2026, its #239 holding.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Sanofi in Q1 2018 and has held it in 19 quarters since.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Sanofi position peaked at $26.8M in Q3 2019.
  • 716 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2026, filed 13 Aug 2026.